Clinical Trials Logo

Clinical Trial Summary

This clinical Trial will assess the effects of a dietary supplement based on Tribulus terrestris on the libido and sexual function in postmenopausal women, by doing a follow up of the FSFI scale and different variables during 3 months period. Participants will be allocated to dietary supplement or placebo, and will attend to 3 visits (baseline, 6 weeks, 12 weeks and at 24 weeks optional).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03820453
Study type Interventional
Source Kern Pharma, S.L.
Contact
Status Recruiting
Phase N/A
Start date October 29, 2018
Completion date August 29, 2019

See also
  Status Clinical Trial Phase
Completed NCT02958176 - Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder N/A
Terminated NCT00572377 - Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder Phase 1
Recruiting NCT04948151 - Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder Phase 2
Completed NCT01382719 - Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder Phase 2
Not yet recruiting NCT06116045 - Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women With Sexual Arousal Disorder Phase 2
Completed NCT05685407 - Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women Phase 1
Terminated NCT03682601 - Sexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment Phase 2
Completed NCT01803802 - Effects of Early Abuse on Adult Intimate Relationships N/A
Completed NCT00640458 - Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder Phase 2